Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude miceLu Wang, Jim Xiang, Yufeng Xie et al.|Breast Cancer Research and Treatment|2013Cited by 48
Direct in vivo evidence of CD4+ T cell requirement for CTL response and memory via pMHC-I targeting and CD40L signalingKhawaja Ashfaque Ahmed, Jim Xiang, Sean J. Mulligan et al.|Journal of Leukocyte Biology|2012Cited by 34
Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responsesYufeng Xie, J Xiang, Jianqing Xu et al.|Cancer Gene Therapy|2013Cited by 17